Skip to main content Accessibility help
×
Home

The trypanosome alternative oxidase: a potential drug target?

  • STEFANIE K. MENZIES (a1), LINDSAY B. TULLOCH (a1), GORDON J. FLORENCE (a1) and TERRY K. SMITH (a1)

Summary

New drugs against Trypanosoma brucei, the causative agent of Human African Trypanosomiasis, are urgently needed to replace the highly toxic and largely ineffective therapies currently used. The trypanosome alternative oxidase (TAO) is an essential and unique mitochondrial protein in these parasites and is absent from mammalian mitochondria, making it an attractive drug target. The structure and function of the protein are now well characterized, with several inhibitors reported in the literature, which show potential as clinical drug candidates. In this review, we provide an update on the functional activity and structural aspects of TAO. We then discuss TAO inhibitors reported to date, problems encountered with in vivo testing of these compounds, and discuss the future of TAO as a therapeutic target.

Copyright

Corresponding author

*Corresponding author. Biomedical Sciences Research Complex, University of St Andrews, St Andrews, Fife, Scotland KY16 9ST, UK. E-mail: tks1@st-andrews.ac.uk

References

Hide All
Ajayi, W., Chaudhuri, M. and Hill, G. C. (2002). Site-directed mutagenesis reveals the essentiality of the conserved residues in the putative diiron active site of the trypanosome alternative oxidase. Journal of Biological Chemistry 277, 81878193.
Andersson, M. E. and Nordlund, P. (1999). A revised model of the active site of alternative oxidase. FEBS Letters 449, 1722.
Baker, N., de Koning, H. P., Mäser, P. and Horn, D. (2013). Drug resistance in African trypanosomiasis: the pelarsoprol and pentamidine story. Trends in Parasitology 29, 110118.
Barrett, M. P., and Croft, S. L. (2012). Management of trypanosomiasis and leishmaniasis. British Medical Bulletin 104, 175196.
Berthold, D. A., Andersson, M. E. and Nordlund, P. (2000). New insight into the structure and function of the alternative oxidase. Biochimica et Biophysica Acta 1460, 241254.
Berthold, D. A., Voevodskaya, N., Stenmark, P., Gräslund, A. and Nordlund, P. (2002). EPR studies of the mitochondrial alternative oxidase: evidence for a Diiron Carboxylate Center. Journal of Biological Chemistry 277, 4360843614.
Bringaud, F., Barrett, M. P. and Zilberstein, D. (2012). Multiple roles of proline transport and metabolism in Trypanosomatids. Frontiers in Bioscience 17, 349374.
Chaudhuri, M., and Hill, G. C. (1996). Cloning, sequencing and functional activity of the Trypanosoma brucei brucei alternative oxidase . Molecular and Biochemical Parasitology 83, 125129.
Chaudhuri, M., Wilfred, A. and Hill, G. C. (1998). Biochemical and molecular properties of the Trypanosoma brucei alternative oxidase. Molecular and Biochemical Parasitology 95, 5368.
Chaudhuri, M., Wilfred, A., Temple, S. and Hill, G. C. (1995). Identification and partial purification of a stage-specific 33 kDa mitochondrial protein as the alternative oxidase of the Trypanosoma brucei brucei bloodstream Trypomastigotes. The Journal of Eukaryotic Microbiology 42, 467472.
Clarkson, A. B. and Brohn, F. H. (1976). Trypanosomiasis: an approach to chemotherapy by the inhibition of carbohydrate catabolism. Science (New York, N.Y.) 194, 204206.
Clarkson, A. B., Bienensb, E. J., Pollakisz, G. and Gradyll, W. (1989). Respiration of bloodstream forms of the parasite Trypanosoma brucei brucei is dependent on a plant-like alternative oxidase. Journal of Biological Chemistry 264, 1777017776.
Fang, J., and Beattie, D. S. (2003). Alternative oxidase present in Procyclic Trypanosoma brucei May act to lower the mitochondrial production of superoxide. Archives of Biochemistry and Biophysics 414, 294302.
Fukai, Y., Amino, H., Hirawake, H., Yabu, Y., Ohta, N., Minagawa, N., Sakajo, S., Yoshimoto, A., Nagai, K., Takamiya, S., Kojima, S. and Kita, K. (1999). Functional expression of the Ascofuranone-sensitive Trypanosoma brucei Brucei alternative oxidase in the Cytoplasmic Membrane of Escherichia Coli. Comparative Biochemistry and Physiology. Part C, Pharmacology, Toxicology & Endocrinology 124, 141148.
Fukai, Y., Coichi, N., Keisuke, K., Yoshisada, Y. and Suzuki, T. (2003). Overproduction of highly active trypanosome alternative oxidase in Escherichia coli heme-deficient mutant. Parasitology International 52, 237–2p41.
Grady, R. W., Bienen, E. J., Dieck, H. A., Saric, M. and Clarkson, A. B. (1993). N-N-alkyl-3,4-dihydroxybenzamides as inhibitors of the trypanosome alternative oxidase: activity in vitro and in vivo. Antimicrobial Agents and Chemotherapy 37, 10821085.
Grant, P. T. and Sargent, J. R. (1960). Properties of L-alpha-glycerophosphate oxidase and its role in the respiration of Trypanosoma Rhodesiense. The Biochemical Journal 76, 229237.
Helfert, S., Estévez, A. M., Bakker, B., Michels, P. and Clayton, C. (2001). Roles of triosephosphate isomerase and Aerobic metabolism in Trypanosoma brucei . Biochemical Journal 357(Pt 1), 117125.
Kido, Y., Shiba, T., Inaoka, D. K., Sakamoto, K., Nara, T., Aoki, T., Honma, T., Tanaka, A., Inoue, M., Matsuoka, S., Moore, A., Harada, S. and Kita, K. (2010). Crystallization and preliminary crystallographic analysis of cyanide-insensitive alternative oxidase from Trypanosoma brucei brucei . Acta Crystallographica Section F, Structural Biology and Crystallization Communications 66(Pt 3). International Union of Crystallography: 275278.
Kuepfer, I., Schmid, C., Allan, M., Edielu, A., Haary, E. P., Kakembo, A., Kibona, S., Blum, J. and Burri, C. (2012). Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage Rhodesiense sleeping sickness. PLoS Neglected Tropical Diseases 6, e16955.
Li, X. W., Herrmann, J., Zang, Y., Grellier, P., Prado, S., Muller, R. and Nay, B. (2013). Synthesis and biological activities of the respirator chain inhibitor aurachin D and new ring versus chain analogues. Beilstein Journal of Organic Chemistry 9(Figure 1), 15511558.
Lüscher, A., de Koning, H. P. and Mäser, P. (2007). Chemotherapeutic strategies against Trypanosoma brucei: drug targets vs. drug targeting. Current Pharmaceutical Design 13, 555567.
Marechal, A., Kido, Y., Kita, K., Moore, A. L. and Rich, P. R. (2009). Three redox states of Trypanosoma brucei alternative oxidase identified by infrared spectroscopy and electrochemistry. Journal of Biological Chemistry 284, 3182731833.
Minagawa, N., Yabu, Y., Kita, K., Nagai, K., Ohta, N., Meguro, K., Sakajo, S.and Yoshimoto, A. (1997). An antibiotic, Ascofuranone, specifically inhibits respiration and in vitro growth of long slender bloodstream forms of Trypanosoma brucei brucei . Molecular and Biochemical Parasitology 81, 127136.
Mogi, T., Ui, H., Shiomi, K., Omura, S., Miyoshi, H. and Kita, K. (2009). Antibiotics LL-Z1272 identified as novel inhibitors discriminating bacterial and mitochondrial quinol oxidases. Biochimica et Biophysica Acta - Bioenergetics 1787, 129133.
Moore, A. L., Carré, J. E., Affourtit, C., Albury, M. S., Crichton, P. G., Kita, K. and Heathcote, P. (2008). Compelling EPR evidence that the alternative oxidase is a diiron carboxylate protein. Article. Biochimica et Biophysica Acta 1777, 327330.
Moore, A. L., Shiba, T., Young, L., Harada, S., Kita, K. and Ito, K. (2013). Unraveling the heater: new insights into the structure of the alternative oxidase. Annual Review of Plant Biology 64, 637663.
Nakamura, K., Fujioka, S., Fukumoto, S., Inoue, N., Sakamoto, K., Hirata, H., Kido, Y., Yabu, Y., Suzuki, T., Watanabe, Y. I., Saimoto, H., Akiyama, H. and Kita, K. (2010). Trypanosome alternative oxidase, a potential therapeutic target for sleeping sickness, is conserved among Trypanosoma brucei subspecies. Parasitology International 59. Elsevier Ireland Ltd: 560564.
Nihei, C., Fukai, Y. and Kita, K. (2002). Trypanosome alternative oxidase as a target of chemotherapy. Biochimica et Biophysica Acta – Molecular Basis of Disease 1587, 234239.
Nihei, C., Fukai, Y., Kawai, K., Osanai, A., Yabu, Y., Suzuki, T., Ohta, N., Minagawa, N., Nagai, K. and Kita, K. (2003). Purification of active recombinant trypanosome alternative oxidase. FEBS Letters 538, 3540.
Opperdoes, F. R., Borst, P. and Fonck, K. (1976). The potential use of inhibitors of glycerol-3-Phosphate oxidase for chemotherapy of African trypanosomiasis. FEBS Letters 62, 169172.
Ott, R., Chibale, K., Anderson, S., Chipeleme, A., Chaudhuri, M., Guerrah, A., Colowick, N. and Hill, G. C. (2006). Novel inhibitors of the trypanosome alternative oxidase inhibit Trypanosoma brucei brucei growth and respiration. Acta Tropica 100, 172184.
Pollakis, G., Grady, R. W., Dieck, H. A. and Clarkson, A. B. (1995). Competition between inhibitors of the trypanosome alternative oxidase (TAO) and reduced coenzyme Q9. Biochemical Pharmacology 50, 12071210.
Saimoto, H., Kido, Y., Haga, Y., Sakamoto, K. and Kita, K. (2013). Pharmacophore identification of Ascofuranone, potent inhibitor of cyanide-insensitive alternative oxidase of Trypanosoma brucei . Journal of Biochemistry 153, 267273.
Schonbaum, G. R., Bonner, W. D., Storey, B. T. and Bahr, J. T. (1971). Specific inhibition of the cyanide-insensitive respiratory pathway in plant mitochondria by hydroxamic acids. Plant Physiology 47, 124128.
Shiba, T., Kido, Y., Sakamoto, K., Ken, D., Tsuge, C. and Tatsumi, R. (2013). Structure of the trypanosome cyanide-insensitive alternative oxidase. Proceedings of the National Academy of Sciences 110, 45804585. doi:10.1073/pnas.1218386110/-/DCSupplemental. www.pnas.org/cgi/doi/10-1073/pnas.1218386110
Simarro, P. P., Cecchi, G., Franco, J. R., Paone, M., Diarra, A., Ruiz-Postigo, J. A., Fèvre, E. M., Mattioli, R. C. and Jannin, J. G. (2012). Estimating and mapping the population at risk of sleeping sickness. PLoS Neglected Tropical Diseases 6, e1859.
Suzuki, T., Nihei, C. I., Yabu, Y., Hashimoto, T., Suzuki, M., Yoshida, A., Nagai, K., Hosokawa, T., Minagawa, N., Suzuki, S., Kita, K. and Ohta, N. (2004). Molecular cloning and characterization of Trypanosoma vivax alternative oxidase (AOX) gene, a target of the Trypanocide Ascofuranone. Parasitology International 53, 235245.
Tsuda, A., Witola, W. H., Konnai, S., Ohashi, K. and Onuma, M. (2006). The effect of TAO expression on PCD-like phenomenon development and drug resistance in Trypanosoma brucei . Parasitology International 55, 135142.
Vassella, E., Probst, M., Schneider, A., Studer, E., Renggli, C. K., and Roditi, I. (2004). Expression of a major surface protein of Trypanosoma brucei insect forms is controlled by the activity of mitochondrial enzymes. Molecular Biology of the Cell 15, 39863993.
Walker, R., Saha, L., Hill, G. C. and Chaudhuri, M. (2005). The effect of over-expression of the alternative oxidase in the procyclic forms of Trypanosoma brucei . Molecular and Biochemical Parasitology 139, 153162.
World Health Organization (2013). Control and Surveillance of Human African Trypanosomiasis. World Health Organization Technical Report Series, no. 984: 1237.
World Health Organization (2016). Human African Trypanosomiasis. http://apps.who.int/gho/data/node.main.A1635?lang=en.
Yabu, Y., Minagawa, N., Kita, K., Nagai, K., Honma, M., Sakajo, S., Koide, T., Ohta, N. and Yoshimoto, A. (1998). Oral and intraperitoneal treatment of Trypanosoma brucei brucei with a combination of Ascofuranone and glycerol in mice. Parasitology International 47, 131137.
Yabu, Y., Yoshida, A., Suzuki, T., Nihei, C. I., Kawai, K., Minagawa, N., Hosokawa, T., Nagai, K., Kita, K. and Ohta, N. (2003). The efficacy of ascofuranone in a consecutive treatment on Trypanosoma brucei brucei in mice. Parasitology International 52, 155164.
Yabu, Y., Suzuki, T., Nihei, C. I., Minagawa, N., Hosokawa, T., Nagai, K., Kita, K. and Ohta, N. (2006). Chemotherapeutic efficacy of ascofuranone in Trypanosoma vivax-infected mice without glycerol. Parasitology International 55, 3943.
Zoltner, M., Horn, D., de Koning, H. P., and Field, M. C. (2016). Exploiting the Achilles’ Heel of membrane trafficking in trypanosomes. Current Opinion in Microbiology 34. Elsevier Ltd: 97103.

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed